Welcoming you for any type of article submission for the upcoming issue on/before February 26, 2021.

Research Article
Volume 5 Issue 6 - 2020
Assessment of Prediction of Relapse of ACTH-Dependent Cushing's Syndrome in Patients Undergoing Transsphenoidal Surgery
Z Yu Halimova1,2 and U A Mirsaidova1*
1Republican Specialized Scientific and Practical Medical Center of Endocrinology of the Ministry of Health of the Republic of Uzbekistan Named After Acad. Y.H. Turakulov, Department of Neuroendocrinology with Pituitary Surgery, Tashkent, Uzbekistan
2Endocrinology with Pediatric Endocrinology Unit, Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan
*Corresponding Author: U A Mirsaidova, Republican Specialized Scientific and Practical Medical Center of Endocrinology of the Ministry of Health of the Republic of Uzbekistan Named After Acad. Y.H. Turakulov, Department of Neuroendocrinology with Pituitary Surgery, Tashkent, Uzbekistan.
Received: May 06, 2020; Published: May 28, 2020


Objective: To analyse the utility of a test with desmopressin to assess the effectiveness of transsphenoidal surgery (TSS) in patients with Cushing’s disease (CD) in the post-operative period.

Design: A prospective study of 42 patients with CD operated in 2012 - 2019 was conducted. Patients were divided into 2 groups: I group-18 patients, postoperative basal cortisol ≤ 138 nmol/L, remission group and IIgr-24 patients with cortisol levels ≥ 138 nmol/L, a risk group for recurrence of the disease, although they had clinical and biochemical remission. All patients underwent a standard test with desmopressin (Newell-Price J, 1997) with a cortisol and ACTH level of 0’, 30’, 60’, 90’, 120'.

Results: The use of TD in the studied groups revealed an increased (hyper reaction) in 16.6% of patients of group I of cortisol in 2 times (on average 280.02 ± 12 nmol/L) and ACTH in 1.4 times (average 14.02 ± 2.06 ng/dl) compared with other patients, the results of which were between 30' and 60' achieved to 166.2 ± 34.4 nmol/L and 15.39 ± 3.4, respectively, which is lower than in the healthy control in 3.5 and 1.5 times with levels of 485.9 ± 25 nmol/l and 23.5 ± 1.79 ng/dl. In group II, 25% (6 patients) also had an increased response to TD between 30' and 60', while the average data in this group were significantly higher by 1.5 times and 6.6 times than group I (p < 0.05, p < 0.01) and lower by 2.6 times and 4.3 times higher than in the control (p < 0.001, p < 0.005).

Conclusion: A complete indicators using modern methods of statistical processing gave us to identify TD as the most sensitive test in determining remission and shows the insufficiency of only determining ACTH and cortisol in this.

Keywords: Cushing’s Disease; Surgery; Desmopressin; Relapse


  1. Acebes JJ., et al. “Early post-operative ACTH and cortisol as predictors of remission in Cushing’s disease”. Acta Neurochirurgica 149 (2007): 471-479.
  2. Alexandraki KI., et al. “Long-term remission and recurrence rates in Cushing’s disease: predictive factors in a single centre study”. European Journal of Endocrinology 168 (2013): 639-648.
  3. Ambrogio AG., et al. “Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease”. Endocrine Connections (2017): 791-799.
  4. Aranda G., et al. “Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up”. Pituitary1 (2015): 142-149.
  5. Arnaldi G., et al. “Diagnosis and complications of Cushing’s syndrome: a consensus statement”. Journal of Clinical Endocrinology and Metabolism 88 (2003): 5593-5602.
  6. Atkinson AB., et al. “Long-term remission rates after pituitary surgery for Cushing’s disease: the need for long-term surveillance”. Clinical Endocrinology 63 (2005): 549-559.
  7. Atkinson AB., et al. “Cyclical Cushing’s syndrome first diagnosed after pituitary surgery: a trap for the unwary”. Clinical Endocrinology3 (1992): 297-299.
  8. Avgerinos PC., et al. “The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing’s syndrome”. Journal of Clinical Endocrinology and Metabolism5 (1987): 906-913.
  9. Barbot M., et al. “Predicting late recurrence in surgically treated patients with Cushing’s diseas”. Clinical Endocrinology 79 (2013): 394-401.
  10. Batista DL., et al. “Postoperative testing to predict recurrent Cushing disease in children”. Journal of Clinical Endocrinology and Metabolism8 (2009): 2757-2765.
  11. Benvensite RJ., et al. “Repeated transsphenoidal surgery to treat recurrent or residual pituitary adenoma”. Neurosurgery 102 (2005): 10041012.
  12. Berker M., et al. “Early promising results for the endoscopic surgical treatment of Cushing’s disease”. Neurosurgical Review 37 (2014): 105-114.
  13. Biller BM., et al. “Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement”. Journal of Clinical Endocrinology and Metabolism 93 (2008): 2454-2462.
  14. Blevins LS Jr., et al. “Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas”. Journal of Clinical Endocrinology and Metabolism 83 (1998): 63-67.
  15. Boscaro M., et al. “Cushing’s syndrome”. Lancet9258 (2001): 783-791.
  16. Chee GH., et al. “Transsphenoidal pituitary surgery in Cushing’s disease: can we predict outcome?” Clinical Endocrinology 54 (2001): 617-626.
  17. Chen JC., et al. “Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test”. Neurosurgery 98 (2003): 967-973.
  18. Colombo P., et al. “Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing’s disease”. European Journal of Endocrinology 143 (2000): 227-234.
  19. Dickerman RD and Oldfield EH. “Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery”. Journal of Neurosurgery 97 (2002): 1343-1349.
  20. Esposito F., et al. “Clinical review: early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease”. The Journal of Clinical Endocrinology and Metabolism 91 (2006): 7-13.
  21. Estrada J., et al. “The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing’s disease”. The Journal of Clinical Endocrinology and Metabolism 86 (2001): 5695-5699.
  22. Grigoriev AYu., et al. “Repeated transsphenoid adenomectomy in relapse and persistent course of Itsenko-Cushing's disease”. Neurosurgery 2 (2014): 49-53.
  23. Hammer GD., et al. “Transsphenoidal microsurgery for Cushing’s disease: initial outcome and long-term results”. The Journal of Clinical Endocrinology and Metabolism 89 (2004): 6348-6357.
  24. Invitti C., et al. “Glucocorticoid receptors in anorexia nervosa and Cushing’s disease”. Biological Psychiatry11 (1999): 1467-1471.
  25. Kirilyuk ML. “Diagnosis and treatment of pituitary Cushing's syndrome”. International Endocrinological Journal62 (2014): 182-193.
  26. Lacroix A., et al. “Cushing’s syndrome”. Lancet 386 (2015): 913-927.
  27. Le Marc’hadour P., et al. “Postoperative follow-up of Cushing’s disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison”. Clinical Endocrinology 83 (2015): 216-222.
  28. Lonser RR., et al. “Outcome of surgical treatment of 200 children with Cushing’s disease”. The Journal of Clinical Endocrinology and Metabolism 98 (2013): 892-901.
  29. Losa M., et al. “Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing’s disease”. Journal of Clinical Endocrinology and Metabolism 94 (2009): 3322-3328.
  30. Losa M., et al. “Desmopressin stimulation test before and after pituitary surgery in patients with Cushing’s disease”. Clinical Endocrinology 55 (2001): 61-68.
  31. Magiakou MA and Chrousos GP. “Cushing’s syndrome in children and adolescents: current diagnostic and therapeutic strategies”. Journal of Endocrinological Investigation2 (2002): 181-194.
  32. Mampalam TJ., et al. “Transsphenoidal microsurgery for Cushing disease. A report of 216 cases”. Annals of Internal Medicine 109 (1988): 487-493.
  33. Newell-Price J., et al. “Cushing’s syndrome”. Lancet 367 (2006): 1605-1617.
  34. Nieman LK., et al. “Treatment of cushing’s syndrome: an endocrine society clinical practice guideline”. Journal of Clinical Endocrinology and Metabolism8 (2015): 2807-2831.
  35. Nieman LK., et al. “The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline”. Journal of Clinical Endocrinology and Metabolism5 (2008): 1526-1540.
  36. Pereira AM., et al. “Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease”. The Journal of Clinical Endocrinology and Metabolism 88 (2003): 5858-5864.
  37. Pivonello R., et al. “The Treatment of Cushing’s Disease”. Endocrine Review4 (2015): 385-486.
  38. Romanholi DJ., et al. “Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing’s disease”. Clinical Endocrinology 69 (2008): 117-122.
  39. Savage MO and Storr HL. “Pediatric Cushing’s disease: management issues”. Indian Journal of Endocrinology and Metabolism2 (2012): S171-S175.
  40. Sonino N., et al. “Risk factors and long-term outcome in pituitary-dependent Cushing’s disease”. The Journal of Clinical Endocrinology and Metabolism 81 (1996): 2647-2652.
  41. Stratakis CA. “Cushing’s syndrome in pediatrics”. Endocrinology and Metabolism Clinics of North America4 (2012): 793-803.
  42. Troshina EA and Kirilyuk ML. “Diagnostics, differential diagnosis and treatment of endogenous hypercorticism”. Problems of Endocrinology2 (2010): 53-63.
  43. Valero R., et al. “The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing’s disease”. European Journal of Endocrinology 151 (2004): 727-733.
  44. Vassiliadi DA., et al. “The desmopressin test predicts better than basal cortisol the long-term surgical outcome of Cushing’s disease”. Journal of Clinical Endocrinology and Metabolism 101 (2016): 4878-4885.
Citation: Z Yu Halimova and U A Mirsaidova. “Assessment of Prediction of Relapse of ACTH-Dependent Cushing's Syndrome in Patients Undergoing Transsphenoidal Surgery”. EC Endocrinology and Metabolic Research 5.6 (2020): 47-59.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

March Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the March issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 03, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.